|European Pharma Summit|
Kinase Inhibitors in Drug Discovery
GPCR Targeted Screening
Drug Design & Medicinal Chemistry
GTCbio and the Advisory Board would like to invite you the 3rd Kinase Inhibitors in Drug Discovery Conference. This event takes place November 16-17, 2017 in Berlin, Germany and is one of 3 co-located conferences at the European Pharma Summit.
The Protein Kinase Inhibitor Design & Screening Conference brings together industry leaders from major pharmaceuticals, biotech companies, and top researchers from academia to provide a timely and critical summary to update significant kinase inhibitors and to better understand current trends for drug design and the screening processes.
Register for this event to hear recent developments in allosteric kinase inhibitors, covalent inhibitor strategies, irreversible and RAF inhibitors, mechanisms of kinase inhibitor resistance, and mutation-focused approaches towards kinase inhibition.
We hope to see you there!
The 2017 Advisory Committee
Amber Kempf at 626-256-6405 x110 or amber.kempf [at] gtcbio.com
For more information on Media Relations, please contact:
Jennifer Chu at 626-256-6405 x105 or jennifer.chu [at] gtcbio.com